Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06541522 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Belt Position on the Results of PEEP Titration by EIT During ARDS

Study acronym: REPEIT
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 21, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date: Aug 2024 to Jan 1, 2025
    • Primary completion date: Aug 2025 to Jan 2026
    • Study completion date: Sep 2025 to Jan 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
ARDS is a frequent reason for hospitalization in intensive care. In order to improve its management, doctors seek to limit the mechanical ventilation-induced injuries (VILI) that can occur. PEEP is a parameter that plays a role in the appearance of VILI, and its adjustment can be optimized by EIT. The EIT is a non-invasive, non-irradiating, real-time monitoring device, today widely used for the optimization of ventilation in patients intubated for ARDS. The positioning of the EIT belt at different chest heights could influence the result of the PEEP titration.
Trial Details
NCT Number NCT06541522
Lead Sponsor Centre Hospitalier Saint Joseph Saint Luc de Lyon
Conditions
(from sponsor)		 ARDS
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov